Literature DB >> 3879797

Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates.

R A Bakay, M S Fiandaca, D L Barrow, A Schiff, D C Collins.   

Abstract

A Parkinson-like syndrome was produced in nonhuman primates and successfully reversed through transplantation of heterologous fetal mesencephalic brain tissue. Rigidity and bradykinesia were induced by the chronic administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Once the deficits were fixed, Macaca mulatta with well-developed Parkinson-like behavior received fetal mesencephalic cell preparations stereotactically implanted into multiple sites of the head of the caudate bilaterally. Both animals demonstrated a normalization of CSF L-dopa and significant improvement in observed activity. The neuropathological studies performed 2 months following transplantation demonstrated successful integration of fetal cells in the caudate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3879797     DOI: 10.1159/000101157

Source DB:  PubMed          Journal:  Appl Neurophysiol


  19 in total

Review 1.  Transplantation into the human brain: present status and future possibilities.

Authors:  O Lindvall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

2.  A policy concerning the therapeutic use of human fetal tissue in transplantation.

Authors:  R M Nelson
Journal:  West J Med       Date:  1990-04

3.  Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.

Authors:  Ming Yang; Angela E Donaldson; Cheryl E Marshall; James Shen; Lorraine Iacovitti
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

4.  Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells.

Authors:  E D Clarkson; F G Rosa; J Edwards-Prasad; D A Weiland; S E Witta; C R Freed; K N Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 5.  The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Authors:  Amanda L Piquet; Kala Venkiteswaran; Neena I Marupudi; Matthew Berk; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2012-04-11       Impact factor: 4.077

6.  Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice.

Authors:  H Widner; P Brundin; A Björklund; E Möller
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 7.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

8.  Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry.

Authors:  D J Clarke; P Brundin; R E Strecker; O G Nilsson; A Björklund; O Lindvall
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 9.  Preclinical assessment of stem cell therapies for neurological diseases.

Authors:  Valerie L Joers; Marina E Emborg
Journal:  ILAR J       Date:  2009

10.  Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release.

Authors:  P Brundin; R E Strecker; H Widner; D J Clarke; O G Nilsson; B Astedt; O Lindvall; A Björklund
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.